Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia : A population-based study from the Swedish AML registry

Lj Lazarevic, Vladimir LU ; Rosso, Aldana LU ; Juliusson, Gunnar LU ; Antunovic, Petar ; Derolf, Åsa Rangert ; Deneberg, Stefan ; Möllgård, Lars ; Uggla, Bertil ; Wennström, Lovisa and Wahlin, Anders , et al. (2017) In European Journal of Haematology 98(5). p.493-500
Abstract

OBJECTIVES AND METHODS: To ascertain the incidence/clinical implications of isolated autosomal trisomies in adult acute myeloid leukemia (AML), all such cases were retrieved from the Swedish AML Registry.

RESULTS: Of the 3179 cytogenetically informative AMLs diagnosed January 1997-May 2015, 246 (7.7%) had isolated trisomies. The frequency increased by age (2.4% at age 18-60 years vs. 23% at >60 years; P<.0001); the median age was 69 years. The five most common were +8 (4.0%), +13 (0.9%), +11 (0.8%), +21 (0.7%), and +4 (0.5%). Age and gender, types of AML and treatment, and complete remission and early death rates did not differ between the single trisomy and the intermediate risk (IR) groups or among cases with isolated... (More)

OBJECTIVES AND METHODS: To ascertain the incidence/clinical implications of isolated autosomal trisomies in adult acute myeloid leukemia (AML), all such cases were retrieved from the Swedish AML Registry.

RESULTS: Of the 3179 cytogenetically informative AMLs diagnosed January 1997-May 2015, 246 (7.7%) had isolated trisomies. The frequency increased by age (2.4% at age 18-60 years vs. 23% at >60 years; P<.0001); the median age was 69 years. The five most common were +8 (4.0%), +13 (0.9%), +11 (0.8%), +21 (0.7%), and +4 (0.5%). Age and gender, types of AML and treatment, and complete remission and early death rates did not differ between the single trisomy and the intermediate risk (IR) groups or among cases with isolated gains of chromosomes 4, 8, 11, 13, or 21. The overall survival (OS) was similar in the single trisomy (median 1.6 years) and IR groups (1.7 years; P=.251). The OS differed among the most frequent isolated trisomies; the median OS was 2.5 years for +4, 1.9 years for +21, 1.5 years for +8, 1.1 years for +11, and 0.8 years for +13 (P=.013).

CONCLUSION: AML with single trisomies, with the exception of +13, should be grouped as IR.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Journal Article
in
European Journal of Haematology
volume
98
issue
5
pages
493 - 500
publisher
Wiley-Blackwell
external identifiers
  • pmid:28152233
  • scopus:85014778341
  • wos:000399882100009
ISSN
1600-0609
DOI
10.1111/ejh.12861
language
English
LU publication?
yes
id
fb73da16-5cf8-417b-9b9d-473773f33563
date added to LUP
2017-03-21 21:28:37
date last changed
2023-11-16 18:09:49
@article{fb73da16-5cf8-417b-9b9d-473773f33563,
  abstract     = {{<p>OBJECTIVES AND METHODS: To ascertain the incidence/clinical implications of isolated autosomal trisomies in adult acute myeloid leukemia (AML), all such cases were retrieved from the Swedish AML Registry.</p><p>RESULTS: Of the 3179 cytogenetically informative AMLs diagnosed January 1997-May 2015, 246 (7.7%) had isolated trisomies. The frequency increased by age (2.4% at age 18-60 years vs. 23% at &gt;60 years; P&lt;.0001); the median age was 69 years. The five most common were +8 (4.0%), +13 (0.9%), +11 (0.8%), +21 (0.7%), and +4 (0.5%). Age and gender, types of AML and treatment, and complete remission and early death rates did not differ between the single trisomy and the intermediate risk (IR) groups or among cases with isolated gains of chromosomes 4, 8, 11, 13, or 21. The overall survival (OS) was similar in the single trisomy (median 1.6 years) and IR groups (1.7 years; P=.251). The OS differed among the most frequent isolated trisomies; the median OS was 2.5 years for +4, 1.9 years for +21, 1.5 years for +8, 1.1 years for +11, and 0.8 years for +13 (P=.013).</p><p>CONCLUSION: AML with single trisomies, with the exception of +13, should be grouped as IR.</p>}},
  author       = {{Lj Lazarevic, Vladimir and Rosso, Aldana and Juliusson, Gunnar and Antunovic, Petar and Derolf, Åsa Rangert and Deneberg, Stefan and Möllgård, Lars and Uggla, Bertil and Wennström, Lovisa and Wahlin, Anders and Höglund, Martin and Lehmann, Sören and Johansson, Bertil}},
  issn         = {{1600-0609}},
  keywords     = {{Journal Article}},
  language     = {{eng}},
  month        = {{02}},
  number       = {{5}},
  pages        = {{493--500}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{European Journal of Haematology}},
  title        = {{Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia : A population-based study from the Swedish AML registry}},
  url          = {{http://dx.doi.org/10.1111/ejh.12861}},
  doi          = {{10.1111/ejh.12861}},
  volume       = {{98}},
  year         = {{2017}},
}